Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Biochemical Reagents
  4. Amino Acids
  5. 097150

EGLU, Tocris Bioscience™

Catalog No. 097150
Change view
Click to view available options
Quantity:
50 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
09-715-0 50 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. 09-715-0 Supplier R&D Systems Supplier No. 0971/50
This item is not returnable. View return policy

Description

Highly selective group II mGlu antagonist

Selective antagonist of presynaptically-mediated (1S,3S)-ACPD-induced depression of motoneuron excitation in neonatal rat spinal cord; presumed group II mGlu receptor antagonist. Also available as part of the Group II mGlu Receptor Tocriset™ .

Specifications

CAS 170984-72-2
Molecular Formula C7H13NO4
Synonym eglu, s-alpha-ethylglutamate, 2s-2-amino-2-ethylpentanedioic acid, 2s-alpha-ethylglutamic acid, tocris-0971, 2-ethyl-l-glutamic acid, d01wkr, 2s-?-ethylglutamic acid, l-glutamic acid, 2-ethyl, s-2-amino-2-ethylpentanedioic acid
InChI Key QFYBYZLHPIALCZ-ZETCQYMHSA-N
SMILES CCC(CCC(=O)O)(C(=O)O)N
IUPAC Name (2S)-2-amino-2-ethylpentanedioic acid
Quantity 50 mg
Molecular Weight (g/mol) 175.184
PubChem CID 5311079
Formula Weight 175.18
Percent Purity >95%
Chemical Name or Material EGLU
Show More Show Less

Safety and Handling

Recommended Storage Store at -20°C
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.